首页> 外文期刊>international archives of allergy and immunology >Chemotactic Reactivity of Eosinophils Obtained from Bone Marrow and Peritoneal Cavity of Cyclophosphamide-Treated,iToxocara cani/iis/i-Infected Mice
【24h】

Chemotactic Reactivity of Eosinophils Obtained from Bone Marrow and Peritoneal Cavity of Cyclophosphamide-Treated,iToxocara cani/iis/i-Infected Mice

机译:Chemotactic Reactivity of Eosinophils Obtained from Bone Marrow and Peritoneal Cavity of Cyclophosphamide-Treated,iToxocara cani/iis/i-Infected Mice

获取原文
           

摘要

Chemotactic reactivity of eosinophils obtained from the bone marrow (BM-Eo) of cyclophosphamide-treated, Toxocara canis-infected mice was compared to that of eosinophils obtained from the peritoneal cavity (PEC-Eo). BM-Eo responded well to alanyl-tetrapeptide, a synthetic eosinophil chemotactic factor of anaphylaxis (ECF-A), whereas PEC-Eo did not. Both BM-Eo and PEC-Eo showed almost equally high chemotactic reactivity to parasite-derived ECF, ECF lymphokine and complement-derived ECF. Chemotactic reactivity of BM-Eo to synthetic ECF-A was deactivated by preincubation with ECF-A. Unresponsiveness of PEC-Eo to synthetic ECF-A could be explained by chemotactic deactivation by ECF-A, because an ECF-A-like substance was detected in the ascitic fluid; this substance could deactivate the chemotactic reactivity of BM-Eo to synthetic ECF-A. From these results, BM-Eo are naive and seem to be a good indicator for eosinophilotaxis and its modulation.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号